| Name | Triacetylganciclovir | 
|---|---|
| Synonyms | 
                                
                                [2-[(2-acetamido-6-oxo-3H-purin-9-yl)methoxy]-3-acetyloxypropyl] acetate
                                
                                
                                 2-[(2-Acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-1,3-propanediyl diacetate Acetamide, N-[9-[[2-(acetyloxy)-1-[(acetyloxy)methyl]ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]- T56 BN DN FN HNJ D1OY1OV1&1OV1 GMV1 IQ T56 BN DN FVM INJ B1OY1OV1&1OV1 HMV1 N-[9-[[2-(Acetyloxy)-1-[(acetyloxy)methyl]ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]acetamide  | 
                        
| Description | Triacetyl-ganciclovir is a Ganciclovir derivative. Ganciclovir is an orally active antiviral agent with activity against cytomegalovirus (CMV)[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.5±0.1 g/cm3 | 
|---|---|
| Melting Point | 174 °C | 
| Molecular Formula | C15H19N5O7 | 
| Molecular Weight | 381.34 | 
| Exact Mass | 381.128448 | 
| PSA | 154.50000 | 
| LogP | -0.78 | 
| Index of Refraction | 1.629 | 
| Storage condition | 2~8°C | 
| Hazard Codes | Xi | 
|---|
| 
                                
                                
                                
                                
                                
                                
                                 ~50%  
                                    86357-14-4  | 
                        
| Literature: Boryski, Jerzy; Golankiewicz, Bozenna Synthesis, 1999 , # 4 p. 625 - 628 | 
| 
                                
                                
                                
                                
                                
                                
                                 ~%  
                                    86357-14-4  | 
                        
| Literature: Synthesis, , # 4 p. 625 - 628 |